வளர்சிதை மாற்ற ஒழுங்குமுறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வளர்சிதை மாற்ற ஒழுங்குமுறை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வளர்சிதை மாற்ற ஒழுங்குமுறை Today - Breaking & Trending Today

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2021


Lipocine Announces Financial Results for the First Quarter Ended March 31, 2021
News provided by
Share this article
Share this article
SALT LAKE CITY, May 6, 2021 /PRNewswire/  Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the first quarter ended March 31, 2021 and provided a corporate update.
First Quarter Recent Corporate Highlights
Announced positive topline results from the Phase 2
LiFT ( Liver Fat intervention with oral Testosterone ) clinical study, investigating LPCN 1144 in biopsy-confirmed NASH male subjects
Both LPCN 1144 treatment arms met the primary endpoint, change in hepatic fat fraction via magnetic resonance imaging proton density fat fraction ( MRI-PDFF ), with statistical significance ....

Lipocine Inc , Clarus Therapeutics Inc , Liver Health , Metabolic Regulation , High Fat Diet Induced , Quarter Ended March , Clarus Therapeutics , Private Securities Litigation Reform Act , Consolidated Statements , Months Ended March , கிளாரஸ் சிகிச்சை இன்க் , கல்லீரல் ஆரோக்கியம் , வளர்சிதை மாற்ற ஒழுங்குமுறை , கிளாரஸ் சிகிச்சை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , தொகுக்கப்பட்டு அறிக்கைகள் ,

Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis


Lipocine Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis
News provided by
Share this article
Share this article
SALT LAKE CITY, March 4, 2021 /PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the publication of preclinical results supporting the therapeutic potential of LPCN 1144 in the treatment of and non-alcoholic steatohepatitis ( NASH ) and hepatic fibrosis. The results were featured in a paper entitled Treatment Potential of LPCN 1144 on Liver Health and Metabolic Regulation in a Non–Genomic, High Fat Diet Induced NASH Rabbit Model (Comeglio et al), published in the Journal of Endocrinological Investigation (https://doi.org/10.1007/s40618-021-01522-7). ....

Prnewswire Lipocine Inc , Lipocine Inc , Liver Health , Metabolic Regulation , High Fat Diet Induced , Endocrinological Investigation , Private Securities Litigation Reform Act , கல்லீரல் ஆரோக்கியம் , வளர்சிதை மாற்ற ஒழுங்குமுறை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

CALL FOR ABSTRACTS International Conference on Algal Biomass, Biofuels and Bioproducts (AlgalBBB 2021) — June 14-16, 2021 — ONLINE DEADLINE February 26, 2021 – Advanced BioFuels USA


You will be able to join the event via an online platform which will allow you to:
Easily navigate the programme and live-stream sessions and presentations
Upload your poster presentation and network and chat with attendees
Engage live with other attendees and speakers through chats, polls, virtual networking meetings and more
Invite attendees to one-on-one meetings using an integrated appointment schedule
Access the event via any device – mobile, tablets or desktop
Access all content of the conference on-demand for 1 month
AlgalBBB places a major emphasis on the latest unpublished technical and scientific results, along with discussion and direct interactions with broad spectrum scientists and engineers, funding sponsors, and leaders in the field from all over the world. The conference presents the work of the algae research community through a balanced set of oral presentations and posters selected from the best submissions to the conference. Our li ....

Technologies In Support Of Algal Research , Molecular Engineering , Synthetic Biology , High Value , Metabolic Regulation , Phototrophic Systems , Heterotrophic Systems , Biorefinery Systems , Algal Research , Algal Biofuels , Thermal Catalytic , Algae Including High Value Products , Sustainability Modeling , Algal Production , Fuel Cycle , மூலக்கூறு பொறியியல் , செயற்கை உயிரியல் , உயர் மதிப்பு , வளர்சிதை மாற்ற ஒழுங்குமுறை , வெப்ப வினையூக்கி , பாசி உட்பட உயர் மதிப்பு ப்ராடக்ட்ஸ் , நிலைத்தன்மை மாடலிங் , எரிபொருள் மிதிவண்டி ,